Alembic Pharmaceuticals Limited announced unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, on consolidated basis, the company's net sales/income from operations was INR 7,761.5 million compared with INR 9,301.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,242.8 million compared with INR 3,623.3 million a year ago. Profit from ordinary activities before tax was INR 1,236.8 million compared with INR 3,640.9 million a year ago. Net profit after tax was INR 865.5 million or INR 4.59 per basic and diluted share compared with INR 2,688.7 million or INR 14.26 per basic and diluted share a year ago. For the nine months, on consolidated basis, the company's net sales/income from operations was INR 23,906.7 million compared with INR 25,368.4 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 4,190.0 million compared with INR 8,162.3 million a year ago. Profit from ordinary activities before tax was INR 4,172.7 million compared with INR 8,167.4 million a year ago. Net profit after tax was INR 3,101.2 million or INR 16.45 per basic and diluted share compared with INR 6,296.2 million or INR 33.40 per basic and diluted share a year ago. For the quarter, on standalone basis, the company's net sales/income from operations was INR 8,039.3 million compared with INR 9,061.3 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,741.2 million compared with INR 3,720.2 million a year ago. Profit from ordinary activities before tax was INR 1,740.5 million compared with INR 3,741.5 million a year ago. Net profit after tax was INR 1,378.3 million or INR 7.31 per basic and diluted share compared with INR 2,789.2 million or INR 14.80 per basic and diluted share a year ago. For the nine months, on standalone basis, the company's net sales/income from operations was INR 23,363.2 million compared with INR 24,181.1 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 4,736.6 million compared with INR 7,961.0 million a year ago. Profit from ordinary activities before tax was INR 4,734.0 million compared with INR 7,974.3 million a year ago. Net profit after tax was INR 3,714.0 million or INR 19.70 per basic and diluted share compared with INR 6,093.6 million or INR 32.32 per basic and diluted share a year ago.